Evidence map›Paper›PMID 28455312›Full record

ArticleEMBO molecular medicine2017

Administration of RANKL boosts thymic regeneration upon bone marrow transplantation.

Noella Lopes, Hortense Vachon, Julien Marie, Magali Irla

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Thymic regeneration and tumor immunotherapy.Frontiers in immunology · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Generation and repair of thymic epithelial cells.The Journal of experimental medicine · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Molecular Mechanisms Leading from Periodontal Disease to Cancer.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Noella LopesCentre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille Cedex 09, France.
Hortense VachonCentre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille Cedex 09, France.
Julien MarieDepartment of Immunology Virology and Inflammation, Cancer Research Center of Lyon (CRCL) UMR INSERM1052, CNRS 5286, Lyon, France.
Magali IrlaCentre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille Cedex 09, France magali.irla@inserm.fr.ORCID 0000-0001-8803-9708
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytoablative treatments lead to severe damages on thymic epithelial cells (TECs), which result in delayed

Indexed as

RegenerationAnimalsBone Marrow TransplantationEpithelial CellsLymphotoxin-alphaMiceRadiotherapyRANK LigandThymus GlandTreatment OutcomeLymphotoxin-alphaRANK Ligandbone marrow transplantationlymphotoxin αreceptor activator of nuclear factor kappa B ligandT‐cell reconstitutionthymic regeneration

Identifiers

PMID28455312
PMCPMC5452038
OpenAlexW2608500302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.